Evidence map›Paper›PMID 40246334›Full record

ArticleHeart (British Cardiac Society)2025

Global, regional and national epidemiology of myocarditis: health inequalities, risk factors and forecasted burden based on the Global Burden of Disease Study 2021.

Changjun Li, Kun Xu, Aijia Du, Ningning Fu, Zhaolong Xu, Qinghua Chang

Abstract read
In one paragraph

Article in Heart (British Cardiac Society), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Changjun LiDepartment of General Practice, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Kun XuDepartment of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Aijia DuDepartment of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Ningning FuDepartment of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Zhaolong XuDepartment of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Qinghua ChangDepartment of Cardiology, the First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China changqinghua1986@163.com.ORCID 0000-0003-2150-6206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocarditis is a global epidemic that causes various medical conditions associated with an increased incidence and death numbers. This study aimed to investigate the trends in myocarditis-associated incidence, mortality, and disability-adjusted life-years (DALYs) with health inequalities, risk factors, and predict the disease burden, thereby mitigating the health hazards of myocarditis.

methodsThis was a modelling study that used data from the Global Burden of Diseases 2021, from which myocarditis was included in the analysis. Incidence, death, DALYs, age-standardised incidence rate (ASIR), age-standardised mortality rate (ASMR), age-standardised DALYs rate (ASDR), cases change, corresponding estimated annual percentage change (EAPC), Slope Inequality of Index (SII) and Concentration Index were analysed.

resultsFrom 1990 to 2021, incidence and death cases increased by 66.88% and 45.94%, respectively. The myocarditis-associated incidence and death cases increased in all five sociodemographic index (SDI) regions. Among the five SDI regions, the High SDI region had the highest myocarditis-associated ASIR with the least ASMR and ASDR in 2021. Regionally, Central Asia had the largest increase in EAPC of ASIR, ASMR and ASDR. Among 204 countries, Japan had the highest ASIR in 2021 and Romania had the highest ASMR and ASDR. Between 1990 and 2021, the SII and Concentration Index for DALYs have shown declining trends. The extreme temperatures were major contributors to the burden of myocarditis during 1990-2021. The projections suggested that the myocarditis-related global number of new cases and death would increase over the next 15 years. There may be upward trends in people of 15+of incidence number and 40+of death and DALYs number.

conclusionsMyocarditis is an increasing global health challenge with rising incidence and death. Management of extreme temperatures remains a major challenge. The number of incidence, death and DALYs in different age groups would continue to grow over the next 15 years. Therefore, measures should be taken to target risk factors and high-risk groups.

Indexed as

Global HealthHealth Status DisparitiesMyocarditisAdolescentAdultDisability-Adjusted Life YearsFemaleForecastingGlobal Burden of DiseaseHumansIncidenceMaleMiddle AgedRisk FactorsSocioeconomic FactorsYoung AdultEpidemiologyGlobal Burden of DiseaseMyocarditis

Identifiers

PMID40246334
PMCPMC12421102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.